EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Effect of Huashi Tongbi Formula on Erectile Dysfunction with Damp Heat Affecting Pi (Spleen) Pattern: A Multicentre, Randomized, Controlled Noninferiority Trial

He-de Zou, Pei-Hai Zhang, Wen-Kang Chen, Bao-Feng Hu, Jian-Wei Wang, Hong-Sen Zeng, Guan-Chao Du, Qing-He Gao, Zi-Yang Ma, Yong-Jie Ma, Ya-Peng Zhang, Rui Cao und 4 weitere

Chinese Journal of Integrative Medicine · 2026-02 · 32 (2) · 111-119

DOI: 10.1007/s11655-025-4142-0 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Chinese Journal of Integrative Medicine, online erschienen am 12.09.2025. Verfasst von He-de Zou und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, China. Hauptthemen laut MEDLINE: Erectile Dysfunction, Drugs, Chinese Herbal, Hot Temperature. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To evaluate the effect and safety of Chinese herbal compound Huashi Tongbi Formula (HTF) for the treatment of erectile dysfunction (ED) with damp heat affecting Pi (Spleen) pattern, and explore the possible mechanisms based on the analysis of gut microbiota. METHODS: In this multicentre, randomized, parallel, positive control, noninferiority trial, a total of 162 ED patients with damp heat affecting Pi pattern were randomly divided into a treatment group (108 patients) and a control group (54 patients) in a 2:1 ratio using a random number table method. The treatment group was administered HTF granules (1 bag each time, twice a day). The control group was given sildenafil citrate tablets (50 mg, orally as needed). Both groups were treated for 8 weeks with a 8-week followed-up period. The main indicator was effective rate after 8-week treatment analysed using intention-to-treat (ITT) and per-protocol (PP) methods, and the secondary indicators included International Index of Erectile Function-5 (IIEF-5) score, Erectile Quality Score (EQS), and Chinese medicine syndrome (CMS) score, which were analysed using ITT every 2 weeks during 8-week treatment period, and every 4 weeks during 8-week follow-up period. The 16S rDNA sequencing was used to analyse the impact of HTF on the gut microbiota. The adverse events (AEs) and changes in safety indicators of the two groups were recorded. RESULTS: A total of 162 patients were included in the ITT analysis, with 23 patients dropping out during the trial period (12 in the treatment group and 11 in the control group), and 139 patients were included in the PP analysis. ITT and PP analyses revealed that after 8-week treatment the difference and 95% confidence intervals (CIs) in the effective rates between the treatment and the control groups were -3.7% (-17.9%, 10.5%) and -4.5% (-18.2%, 9.2%), respectively. At 2 weeks of treatment, the treatment group showed lower IIEF-5 and EQS scores but higher CMS score vs. control (P 0.05); by 6 weeks, all scores (IIEF-5, EQS, CMS) were similar between groups (P>0.05); at 8 weeks, IIEF-5 and EQS were comparable, but CMS scores were lower (P 0.05). After HTF treatment, the relative abundances of Lachnospiraceae and Blautia increased, contributing the most to the differences in the microbial communities between groups. The abundances of Levilactobacillus and Lactiplantibacillus increased, whereas the abundances of Bilophila, Saccharimonadia, Patescibacteria, and others decreased in the treatment group (linear discriminant analysis score>2). Nine predictive functions of the gut microbiota including amino acid related enzymes, exosome, mitochondrial biogenesis, etc. were reduced, whereas protein kinase function increased in the treatment group (P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Erectile DysfunctionDrugs, Chinese HerbalHot TemperatureHumansMaleMiddle AgedAdultTreatment OutcomeGastrointestinal Microbiome

Stichwörter der Autor:innen

Chinese medicineHuashi Tongbi Formulaerectile dysfunctiongut microbiotanoninferiorityrandomized controlled trials

Substanzen

Drugs, Chinese Herbal

Autor:innen und Institutionen

  • Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
  • Department of Andrology, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, 100091, China.
  • Department of Andrology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610072, China.
  • The Second Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
  • Graduate School of China Academy of Chinese Medical Sciences, Beijing, 100700, China.
  • Department of Nephropathy, Qian'an Traditional Chinese Medicine Hospital, Tangshan, 064404, China.

Zitieren

APA

Zou, H. D., Zhang, P. H., Chen, W. K., Hu, B. F., Wang, J. W., Zeng, H. S., Du, G. C., Gao, Q. H., Ma, Z. Y., Ma, Y. J., Zhang, Y. P., Cao, R., Zhang, H. K., Lin, W., Xu, H. R., & Zhao, J. Y. (2026). Effect of Huashi Tongbi Formula on Erectile Dysfunction with Damp Heat Affecting Pi (Spleen) Pattern: A Multicentre, Randomized, Controlled Noninferiority Trial. Chinese Journal of Integrative Medicine, 32(2), 111-119. https://doi.org/10.1007/s11655-025-4142-0

Vancouver

Zou HD, Zhang PH, Chen WK, Hu BF, Wang JW, Zeng HS, et al. Effect of Huashi Tongbi Formula on Erectile Dysfunction with Damp Heat Affecting Pi (Spleen) Pattern: A Multicentre, Randomized, Controlled Noninferiority Trial. Chinese Journal of Integrative Medicine. 2026;32(2):111-119. doi:10.1007/s11655-025-4142-0

BibTeX
@article{Zou2026,
  author = {Zou, He-de and Zhang, Pei-Hai and Chen, Wen-Kang and Hu, Bao-Feng and Wang, Jian-Wei and Zeng, Hong-Sen and Du, Guan-Chao and Gao, Qing-He and Ma, Zi-Yang and Ma, Yong-Jie and Zhang, Ya-Peng and Cao, Rui and Zhang, He-Kun and Lin, Wei and Xu, Hao-Ran and Zhao, Jia-You},
  title = {Effect of Huashi Tongbi Formula on Erectile Dysfunction with Damp Heat Affecting Pi (Spleen) Pattern: A Multicentre, Randomized, Controlled Noninferiority Trial},
  journal = {Chinese Journal of Integrative Medicine},
  year = {2026},
  volume = {32},
  number = {2},
  pages = {111--119},
  doi = {10.1007/s11655-025-4142-0}
}
Kostenlos starten →